Abstract
Background
Sentinel lymph node (SN) biopsy is essential for evaluating survival and minimal treatment-related morbidity associated with cervical, endometrial, and vulvar cancer in Japan. As such, our aim in this study was to evaluate the current practice pattern of using SN biopsy for cervical, endometrial, and vulvar cancer in Japan.
Methods
We deployed a 47-question survey on the use of SN biopsy for gynecological cancers to 216 gynecological oncology training facilities. The survey included information on the use of SN biopsy for uterine (cervical and endometrial) and vulvar cancers; details on the type, timing, and concentration of tracers used; surgical approach used for SN biopsy; method of biopsy and pathological examination; and facilities’ experience with clinical research on SN biopsy.
Results
The response rate was 84% (181/216), with 40 facilities (22%) having experience in SN biopsy for gynecological cancers, 34 (85%) for uterine cancers, and 15 (37%) for vulvar cancers. Radioisotope, indocyanine green (ICG), and blue dyes were available for the detection of uterine cancers in 21 (52%), 25 (62%), and 19 (48%) facilities and for vulvar cancers in 9 (22%), 3 (7%), and 11 (27%) facilities, respectively. Thirty-four facilities (85%) used intraoperative frozen section procedure for diagnosis when possible, with 24 (71%) of these facilities using 2-mm specimen cuts. Diagnosis included pathological examination (85%), immunostaining (57%), and one-step nucleic acid amplification (5%).
Conclusion
Increasing research evidence, providing insurance coverage for radioisotope tracers, and increasing the availability of training are expected to increase the use of SN biopsy in Japan.
Similar content being viewed by others
References
Biewenga P, van der Velden J, Mol BWJ et al (2011) Prognostic model for survival in patients with early stage cervical cancer. Cancer 117:768–776
Tejerizo-Garcia A, Jiménez-Lôpez JS, Muñoz-González JL et al (2013) Overall survival and disease-free survival in endometrial cancer: prognostic factors in 276 patients. Onco Targets Ther 9:1305–1313
Hareyama H, Hada K, Goto K et al (2015) Prevalence, classification, and risk factors for postoperative lower extremity lymphedema in women with gynecologic malignancies: a retrospective study. Int J Gynecol Cancer 25:751–757
Newman ML, Brennan M, Passik S (1996) Lymphedema complicated by pain and psychological distress: a case with complex treatment needs. J Pain Symptom Manag 12:376–379
Kirby TO, Rocconi RP, Numnum TM et al (2005) Outcomes of stage I/II vulvar cancer patients after negative superficial inguinal lymphadenectomy. Gynecol Oncol 98:309–312
Rouzier R, Haddad B, Dubernard G et al (1996) Inguinofemoral dissection for carcinoma of the vulva: effect of modifications of extent and technique on morbidity and survival. J Am Coll Surg 196:442–450
Holloway RW, Abu-Rustum NR, Backes FJ et al (2017) Sentinel lymph node mapping and staging in endometrial cancer: a Society of Gynecologic Oncology literature review with consensus recommendations. Gynecol Oncol 146:405–415
Koh WJ, Abu-Rustum NR, Bean S et al (2019) Cervical cancer, version 3.2019, NCCN clinical practice Guidelines in oncology. J Natl Compr Canc Netw 17:64–84
Koh WJ, Abu-Rustum NR, Bean S et al (2018) Uterine neoplasms, version 1.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 16:170–199
Nagase S, Inoue Y, Umesaki N et al (2010) Evidence-based guidelines for treatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO) 2007 Edition. Int J Clin Oncol 15:117–124
Yamagami W, Mikami M, Nagase S et al (2020) Japan Society of Gynecologic Oncology 2018 Guidelines for treatment of uterine body neoplasms. J Gynecol Oncol 31:e18
Lécuru F, Mathevet P, Querleu D et al (2011) Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol 29:1686–1691
Yahata H, Kobayashi H, Sonoda K et al (2018) Prognostic outcome and complications of sentinel lymph node navigation surgery for early-stage cervical cancer. Int J Clin Oncol 23:1167–1172
Ballester M, Dubernard G, Lécuru F et al (2011) Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol 12:469–476
Rossi EC, Kowalkski LD, Scalici J et al (2017) A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol 18:384–392
Bogani G, Murgia F, Ditto A et al (2019) Sentinel node mapping vs. lymphadenectomy in endometrial cancer: a systematic review and meta-analysis. Gynecol Oncol 153:676–683
Van der Zee AG, Oonk MH, De Hullu J et al (2008) Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 26:884–889
Saito T, Tabata T, Ikushima H et al (2018) Japan Society of Gynecologic Oncology Guidelines 2015 for the treatment of vulvar cancer and vaginal cancer. Int J Clin Oncol 23:201–234
Mikami M, Shida M, Shibata T et al (2018) Impact of institutional accreditation by the Japan Society of Gynecologic Oncology on the treatment and survival of women with cervical cancer. J Gynecol Oncol 29:e23
Darai E, Dubernard G, Bats AS et al (2015) Sentinel node biopsy for the management of early stage endometrial cancer: long-term results of the SENTI-ENDO study. Gynecol Oncol 136:54–59
Togami S, Kubo R, Kawamura T et al (2020) Comparison of lymphatic complications between sentinel node navigation surgery and pelvic lymphadenectomy in patients with cervical cancer. Jpn J Clin Oncol 50:543–547
Tanaka T, Terai Y, Fujiwara S et al (2018) The detection of sentinel lymph nodes in laparoscopic surgery can eliminate systemic lymphadenectomy for patients with early stage endometrial cancer. Int J Clin Oncol 23:305–313
Togami S, Kawamura T, Fukuda M et al (2018) Initial report of sentinel lymph node identification during laparoscopic radical hysterectomy using a new gamma probe technology. J Laparoendosc Adv Surg Tech A 28:864–866
Yamashita T, Katayama H, Kato Y et al (2009) Management of pelvic lymph nodes by sentinel node navigation surgery in the treatment of invasive cervical cancer. Int J Gynecol Cancer 19:1113–1118
Please provide the completed details for reference [25]
Kato H, Todo Y, Minobe SI et al (2011) Previous conization on patient eligibility of sentinel lymph node detection for early invasive cervical cancer. Int J Gynecol Cancer 21:1491–1494
Niikura H, Okamoto S, Otsuki T et al (2012) Prospective study of sentinel lymph node biopsy without further pelvic lymphadenectomy in patients with sentinel lymph node-negative cervical cancer. Int J Gynecol Cancer 22:1244–1250
Togami S, Kawamura T, Fukuda M et al (2018) Prospective study of sentinel lymph node mapping for endometrial cancer. Int J Gynaecol Obstet 143:313–318
Niikura H, Okamura C, Akahira J et al (2004) Sentinel lymph node detection in early cervical cancer with combination 99mTc phytate and patent blue. Gynecol Oncol 94:528–532
Ogawa S, Kobayashi H, Amada S et al (2010) Sentinel node detection with (99m)Tc phytate alone is satisfactory for cervical cancer patients undergoing radical hysterectomy and pelvic lymphadenectomy. Int J Clin Oncol 15:52–58
Niikura H, Kaiho-Sakuma M, Tokunaga H et al (2013) Tracer injection sites and combinations for sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol 131:299–303
Kataoka F, Susumu N, Yamagami W et al (2016) The importance of para-aortic lymph nodes in sentinel lymph node mapping for endometrial cancer by using hysteroscopic radio-isotope tracer injection combined with subserosal dye injection: prospective study. Gynecol Oncol 140:400–404
Nagai T, Niikura H, Okamoto S et al (2015) A new diagnostic method for rapid detection of lymph node metastases using a one-step nucleic acid amplification (OSNA) assay in endometrial cancer. Ann Surg Oncol 2015:980–986
Yamagami W, Susumu N, Kataoka F et al (2017) A comparison of dye versus fluorescence methods for sentinel lymph node mapping in endometrial cancer. Int J Gynecol Cancer 27:1517–1524
Tanaka T, Terai Y, Ashihara K et al (2017) The detection of sentinel lymph nodes in laparoscopic surgery for uterine cervical cancer using 99m-technetium-tin colloid, indocyanine green, and blue dye. J Gynecol Oncol 28:e13
Lin H, Ding Z, Kota VG et al (2017) Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis. Oncotarget 8:46601–46610
Ruscito I, Gasparri ML, Braicu EI et al (2016) Sentinel node mapping in cervical and endometrial cancer: indocyanine green versus other conventional dyes—a meta-analysis. Ann Surg Oncol 23:3749–3756
Persson J, Salehi S, Bollino M et al (2019) Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)-the final step towards a paradigm shift in surgical staging. Eur J Cancer 116:77–85
Chambers LM, Vargas R, Michener CM (2019) Sentinel lymph node mapping in endometrial and cervical cancer: a survey of practices and attitudes in gynecologic oncologists. J Gynecol Oncol 30:e35
Vercellino GF, Erdemoglu E, Lichtenberg P et al (2019) A GCIG international survey: clinical practice patterns of sentinel lymph node biopsies in cervical cancer. Arch Gynecol Obstet 300:191–199
Casarin J, Multinu F, Abu-Rustum N et al (2019) Factors influencing the adoption of the sentinel lymph node technique for endometrial cancer staging: an international survey of gynecologic oncologists. Int J Gynecol Cancer 29:60–67
Te Grootenhuis NC, van der Zee AG, van Doorn HC et al (2016) Sentinel nodes in vulvar cancer: long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I. Gynecol Oncol 140:8–14
Zigras T, Kupets R, Barbera L et al (2019) Uptake of sentinel lymph node procedures in women with vulvar cancer over time in a population-based study. Gynecol Oncol 153:574–579
Sakae C, Yamaguchi K, Matsumura N et al (2016) Groin lymph node detection and sentinel lymph node biopsy in vulvar cancer. J Gynecol Oncol 27:e57
Acknowledgements
We are grateful to the 40 facilities that responded with the data on sentinel lymph node biopsy. The 40 facilities are as follows: Aichi Cancer Center, Asahikawa Medical College, Cancer Institute Hospital, Chiba University, Dokkyo Medical University, Fukui University, Gifu Prefectural General Medical Center, Gunma Prefectural Cancer Center, Hokkaido Cancer Center, Hakodate Municipal Hospital. Jikei University, Jikei University Daisan Hospital, Juntendo University, Kagoshima University, Kameda Medical Center, Kansai Medical University, Keio University, Kindai University, Kitakyushu Municipal Medical Center, Kobe City Medical Center General Hospital, Koshigaya Municipal Hospital, Kurume University, Kyoundo Hospital, Kyushu University, Mie University, National Hospital Organization Kyushu Cancer Center, Osaka International Cancer Institute, Osaka Medical College, Osaka University, Shinshu University, Shin-yurigaoka General Hospital, Tazuke Kofukai Medical Research Institute Kitano Hospital, Teikyo University, Tohoku University, University of Occupational and Environmental Health, Toyama Prefectural Central Hospital, Toyohashi Municipal Hospital, Yamagata University, Yokohama Municipal Citizen's Hospital.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No author has any conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Togami, S., Kobayashi, H., Niikura, H. et al. Survey of the clinical practice pattern of using sentinel lymph node biopsy in patients with gynecological cancers in Japan: the Japan Society of Gynecologic Oncology study. Int J Clin Oncol 26, 971–979 (2021). https://doi.org/10.1007/s10147-021-01862-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-021-01862-7